LP.8.1

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

The 2026-2027 vaccine targets the XFG variant to more closely match current variants

The mRNA-based therapy, used with Keytruda, is designed specifically for each patient

The treatment is for cerebral adrenoleukodystrophy, a rare neurodegenerative disease

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

Mukherjee has previously held senior leadership roles at Moderna and GSK

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually

Up to 50% of allogeneic haematopoietic stem cell transplant patients develop chronic GVHD

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths

The recommendation for the subcutaneous formulation follows encouraging trial data

The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment